End-to-End Innovations - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

End-to-End Innovations
Integrated lines, flexible machines, and high-barrier materials enhance packaging options.


Pharmaceutical Technology
Volume 33, Issue 3, pp. 52-58

Materials

Pack Expo International also featured several materials of interest to pharmaceutical packagers. A new family of high-barrier metallized polyethylene terephthalate (PET) films serves as a low-cost, lightweight alternative to foil laminations. A 36-gauge metallized PET can replace a 48-gauge foil lamination, which could be expensive and complex. The metallized film bolsters source-reduction efforts by eliminating the need for a sealant layer. Resistant to delamination and compatible with hard-to-hold products, the thin, multilayer films offer oxygen-transmission rates ranging from < 0.01 to 0.15 cm3/100 in.2/day and water-vapor transmission rates ranging from 0.03 to 0.15 g/100 in.2/day ("LumLife MK" PET film, Toray Plastics America, North Kingstown, RI).

Another potential foil replacement is a clear film that offers a strong barrier to oxygen and moisture. The product combines an polychlorotrifluoroethylene (PCTFE) fluoropolymer layer and a polyvinylidene chloride (PVDC) coating. The four-layer polyvinyl chloride (PVC)–PVDC–PCTFE–PVC structure is designed for the most sensitive pharmaceuticals and nutraceuticals. Because PVC is the contact layer, the film does not require special tooling on form–fill–seal equipment. Also available in an opaque version, the film exhibits excellent lay-flat characteristics ("Pentapharm kpMax" films, Klöckner Pentaplast Group, Gordonsville, VA).

A new solvent-free foil lamination designed especially for pharmaceutical overwrap applications is an extrusion-coated 48-gauge PET–low-density polyethylene–35-gauge foil–metallocene PE structure. Despite a significantly thinner sealant layer than competing materials, the metallocene PE forms stronger weld seals at speeds higher than 100 ft/min. Typical applications include secondary packaging for blow–fill–seal unit-dose containers for inhalation therapy or diagnostic kits. Reverse- or surface-printed white or natural foil structure can be supplied in rollstock form or as premade pouches or die-cut lids ("Triad" foil lamination, Rollprint Packaging Products, Addison, IL).

Hallie Forcinio is Pharmaceutical Technology's Packaging Forum editor, 4708 Morningside Drive, Cleveland, OH 44109, tel. 216.351.5824, fax 216.351.5684,


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology,
Click here